Los Angeles, CA, United States of America

Earl A Hubbell

This inventor holds 55 USPTO granted patents and 45 published patent applications and 7 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Affymetrix, Inc., Life Technologies Corporation, Grail, Inc.. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Earl A Hubbell. Retrieved from https://idiyas.com/inventor/earl-a-hubbell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 55 

% Patents Active = 83.6

 

Average Co-Inventor Count = 2.3

ph-index = 14

Forward Citations = 2,363(Granted Patents)

Forward Citations (Not Self Cited) = 2,232(Dec 10, 2025)


Location History:

  • Mt. View, CA (US) (1996 - 1999)
  • Los Angles, CA (US) (2002)
  • Los Angeles, CA (US) (2000 - 2010)
  • Mountain View, CA (US) (1999 - 2011)
  • Palo Alto, CA (US) (2008 - 2024)

Company Filing History:


Years Active: 1996-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Analysis
Tumor Detection
Sequencing Methods
Genotype Determination
Combinatorial Barcode Sequences
Photolithographic Synthesis
Probe Array Data
Variant Estimation
Methylation Patterns
Single Nucleotide Polymorphisms
Background Signal
Sample Identification
55 patents (USPTO):Explore Patents

Title: Earl A Hubbell: Innovator in DNA Sequencing Technologies

Introduction:

Earl A Hubbell, a prolific inventor based in Los Angeles, CA, has made significant contributions to the field of DNA sequencing. With an impressive portfolio of 49 patents, Hubbell has revolutionized methods, systems, and computer-readable media for efficient and accurate DNA sequencing. His latest patents highlight his advancements in repeat sequencing techniques and variant likelihood evaluation. Let's explore Earl A Hubbell's career highlights and notable collaborations in this article.

Latest Patents:

In his recent patents, Earl A Hubbell has focused on refining the process of DNA sequencing. His method for repeat sequencing involves conducting multiple sequencing processes using different predetermined orderings of nucleotides and reagents. By combining the results obtained from these processes, a more accurate sequence of bases can be determined. This breakthrough has the potential to enhance the accuracy and efficiency of DNA sequencing.

Another notable patent by Hubbell involves evaluating variant likelihood. By providing a plurality of DNA template strands, sequencing primers, and polymerase on a sensor array, Hubbell's system enables the measurement of ensemble sequencing reads. The likelihood of a variant sequence being present is then evaluated by modifying model-predicted values using bias factors specific to forward and reverse strands. This innovation paves the way for improved variant detection and analysis.

Career Highlights:

Earl A Hubbell has made significant contributions during his career, marking him as a prominent figure in the field of DNA sequencing. His expertise lies in developing methods and technologies that overcome the challenges associated with accurate and efficient DNA analysis. Through his collaboration with companies such as Affymetrix, Inc. and Life Technologies Corporation (now part of Thermo Fisher Scientific), Hubbell's innovative ideas have found practical application on large scales.

Collaborations:

Throughout his career, Earl A Hubbell has collaborated with esteemed colleagues who share his passion for advancing DNA sequencing technologies. One such collaborator is MacDonald S Morris, who has worked closely with Hubbell to develop cutting-edge sequencing methods. Another notable co-worker is Robert J Lipshutz, whose expertise has complemented Hubbell's work in designing and optimizing DNA sequencing systems.

Conclusion:

Earl A Hubbell has left an indelible mark on the field of DNA sequencing with his numerous patents and groundbreaking solutions. His inventions have significantly advanced the accuracy, reliability, and efficiency of DNA analysis. Hubbell's collaborations with esteemed colleagues and his association with renowned companies further underscore his contributions to the scientific community. As we move towards a future of personalized medicine and precision genomics, innovators like Earl A Hubbell continue to play a vital role in shaping the landscape of genetic research and analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…